Researchers have uncovered that SSRIs, specifically escitalopram, not only improve mood in depressed patients but also enhance cognitive functions such as verbal memory. This improvement is linked to a reduction in the brain’s 5HT4 serotonin receptors. Further studies aim to investigate drugs targeting these receptors to potentially treat cognitive deficits in depression, affirming the critical […]
Source link